XVIVO Perfusion
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, XVIVO Perfusion sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
XVIVO Perfusion: 3 sponsored US clinical trials, 2 recruiting.
XVIVO Perfusion sponsors 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. The most-studied condition in this pipeline is Transplant; Failure, Heart, with 2 trials.
Upper-quartile sponsor footprint
XVIVO Perfusion sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
NCT06895070
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
NCT05101460
XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
NCT05881278
Therapeutic Areas
What is open in the XVIVO Perfusion pipeline
2 recruiting of 3 indexed (67% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Transplant; Failure, Heart (2 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
XVIVO Perfusion: open-pipeline peers nationwide
Peers matched on 3 registered trials and 67% open enrollment, not the therapeutic-area sidebar.
XVIVO Perfusion sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 67% open enrollment (± trial volume)
- Abbisko Therapeutics Co · 67% recruiting · 6 trials
- ABL Bio · 67% recruiting · 3 trials
- Accelerated Cure Project for Multiple Sclerosis · 67% recruiting · 3 trials
- Advanced Reconstructive Surgery Alliance · 67% recruiting · 3 trials
Related
What to do with this XVIVO Perfusion page
3 registered trials is a research-attention snapshot, not an endorsement of XVIVO Perfusion or any single study.
- 2 of XVIVO Perfusion's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Transplant; Failure, Heart is the condition XVIVO Perfusion studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Transplant; Failure, Heart trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
XVIVO Perfusion pipeline card: 3 registered trials from official public datasets.Report a data error.